HUTCHMED (China) (HMDCF) Dividend Coverage Ratio (2021)
HUTCHMED (China)'s (HMDCF) quarterly Dividend Coverage Ratio came in at 2.45 in Q4 2021, up 39.19% quarter-over-quarter from 1.76 in Q3 2021.
Powered by 
Analysis
HUTCHMED (China) (HMDCF) Dividend Coverage Ratio (2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Dividend Coverage Ratio for 1 consecutive years, with 2.45 the latest figure, recorded in Q4 2021.
- On a quarterly basis, Dividend Coverage Ratio changed N/A year-over-year to 2.45 in Q4 2021; TTM through Dec 2021 was 58.25, a N/A change from a year earlier, with the FY2025 full-year figure at 3.58, up 876.86% from the prior year.
- Dividend Coverage Ratio was 2.45 for Q4 2021 at HUTCHMED (China), up from 1.76 in the prior quarter.
- Over five years, Dividend Coverage Ratio peaked at 2.45 in Q4 2021 and troughed at 1.76 in Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.55 Bn | 197.56 Bn | 7.24 Bn | 1.74 |
| 2 | Gilead Sciences | 181.17 Bn | 177.99 Bn | 6.22 Bn | -10.18 |
| 3 | Vertex Pharmaceuticals | 132.18 Bn | 124.33 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.50 Bn | 74.50 Bn | 3.93 Bn | 13.40 |
| 5 | Argenx Se | 61.66 Bn | 56.48 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.61 Bn | 49.47 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.17 Bn | 30.86 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.04 Bn | 30.04 Bn | 1.16 Mn | - |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |